Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ç÷¿ªÇÐÀû ³úÇãÇ÷ȯÀÚ¿¡¼­ ¿ìȸ·Î ¼ö¼ú¿¡ ÀÇÇÑ Ç÷·ù¿¹ºñ´É·Â Çâ»ó¿¡ ´ëÇÑ ¿¬±¸ Improvement of Cerebrovascular Reserve Capacity by Bypass Surgery in Patients with Hemodynamic Cerebral Ischemia

´ëÇѽŰæ¿Ü°úÇÐȸÁö 1999³â 28±Ç 1È£ p.35 ~ 41
¼Ò¼Ó »ó¼¼Á¤º¸
³ªÇü±Õ ÀÌ°æÁø/Á¶°æ±Ù/¹Ú¼ºÂù/¹ÚÇØ°ü/Á¶Á¤±â/Áöö/¼ÕÇü¼±/°­Áرâ

Abstract

°á·Ð
ÀúÀÚµéÀº 14·ÊÀÇ Ç÷¿ªÇÐÀû ³úÇãÇ÷ȯÀÚ¿¡¼­ ¿ìȸ·Î ¼ö¼úÀ» ½ÃÇàÇÏ¿´À¸¸ç, ±× °á°ú¸¦ ºÐ¼®
ÇÏ¿© ´ÙÀ½°ú °°Àº °á·ÐÀ» ¾ò¾ú´Ù.
¿ìȸ·Î ¼ö¼úȯÀÚ ¼±Åÿ¡ ½ÅÁßÀ» ±âÇؾßÇϸ®¶ó »ý°¢ÇÑ´Ù. ÀúÀÚµéÀÇ ¼ö¼úÀûÀÀ±âÁØÀº ¸ÕÀú
³úÇãÇ÷¹ßÀÛÀÇ º´·ÂÀÌ Àִ ȯÀÚ¿¡¼­ ³úÇ÷°ü ÃÔ¿µ»ó ³úÇ÷°üÀÇ ¿ÏÀü Æó¼â³ª 80%ÀÌ»ó ÇùÂøÀÌ
Àִ ȯÀÚ¸¦ ÀÏÂ÷´ë»óÀ¸·Î ÇÑ´Ù. À̵é ȯÀÚ¿¡¼­ ¾ÈÁ¤½Ã ¹× AcetazolamideÅõ¿©ÈÄÀÇ ³úÇ÷·ù·®
À» ÃøÁ¤ÇÏ¿© ¾ÈÁ¤½Ã ³úÇ÷·ù·®ÀÌ º´º¯ºÎÀ§°¡ ¹Ý´ëÆíº¸´Ù 10%ÀÌ»ó °¨¼ÒµÇ¾îÀÖÀ¸¸ç(AI<0.9),
AcetazolamideÅõ¿©ÈÄÀÇ AI°¡ Åõ¿©Àüº¸´Ù 10£¥ÀÌ»ó °¨¼Ò¸¦ º¸Àο¹¸¦ ´ë»óÀ¸·Î ÇÏ¿´À¸¸ç, ÀÌ
µé ±âÁØ¿¡ ÀÇÇÑ ¼ö¼ú°á°ú 12·Ê(95.7%)¿¡¼­ Ç÷·ù¿¹ºñ´É·ÂÀÇ »ó½ÂÀ» º¼ ¼ö ÀÖ¾ú´Ù.
#ÃÊ·Ï#
To study the effect of extracranial-intracranial(EC/IC) bypass on symptomatic patients
with hemodynamic cerebral ischemia, we prospectively reviewed 14 patients who
underwent EC/IC bypass surgery. A series of 14 patients treated in a 2 years period
met the following criteria, 1) symptomatic internal carotid artery(ICA) or middle cerebral
aetery(MCA) obstruction or stenosis over 80£¥, 2) decrease in basal cerebral blood
flow(CBF) over 10£¥, 3) hyporeactivity to acetazolimide of CBF. Among these, the type
of ischemic episode was transient ischemic attack(TIA) or reversible ischemic
neurological deficit(RIND) in 4, minor stroke in 8, and major stroke in 2. Of these, 10
patients had multiple episode of ischemic attack. CT or MRI were showed infarction of
the MCA territory in 3, border zone infarction in 5, basal ganglia infarction in 2 and
multiple lacunar infarction in 4. Based on our criteria, superficial temporal
artery(STA)-MCA anastomosis was performed in 13 cases and EC-IC bypass grafting
using radial artery in one. Average follow up period was 24 months. Postoperative
course was uneventful in 12 patients. One patient suffered a postoperative stroke with
complete recovery and another suffered operative would infection. Of the 14 patients,
12(85.7£¥) have had an excellent to good outcome with complete resolution or significant
improvement of preoperative neurologic symptom, remaining two show no improvement
of preoperative neurologic deficit. Bypass patency was confirmed by postoperative
angiography in all cases except for one. Postoperative follow up studies of the basal
CBF and response to the acetazolamide of the CBF showed significant increased CBF
activity to acetazolamide in 12 cases(85.7£¥) while the basal CBF was essentially
unchanged in all cases except for two. In view of these finding, the authors suggest
that EC-IC bypass surgery to be considered as an appropritate therapy for improvement
of the cerebrovascular reserve capacity in patients with hemodynamic cerebral ischemia,
defined using the strict selection criteria employed in this study.

Extracranial-Intracranial bypass surgery; Occlusive vascular disease; Cerebral blood flow; Hemodynamic cerebral ischemia; Acetazolamide; Cerebrovascular reserve capacity;

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS